MedTrace Logo

Autism Research Project With Non-Invasive Near-Infrared Light Stimulation

NCT06203938 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2025-07-18

No results posted yet for this study

Summary

The investigators have previously shown that the administration of low-level infrared light is a safe and non-invasive procedure which improves cognition and emotion, as well as enhances brain metabolic activity. Based on previous studies, the investigators hypothesize that this methodology, called low-level light therapy or photobiomodulation, could be used to improve behavioral symptoms in individuals with autism spectrum disorder (ASD).

Conditions

Interventions

DEVICE

Transcranial infrared light stimulation

Trancranial infrared light stimulation administered via light-emitting diodes

DEVICE

Sham

Identical to TILS, but with lights off

Sponsors & Collaborators

  • University of Texas at Austin

    lead OTHER

Principal Investigators

  • Sarah W Diaz, PhD · University of Texas at Austin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
4 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-13
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06203938 on ClinicalTrials.gov